Pitfalls in the radiological and pathological correlation of tumour response rates of hepatocellular carcinoma following radiofrequency ablation

Journal of Clinical Pathology

Volumn 62, Issue 12, 2009, Pages 1071-1073

  Cho, Y K ^a   Kim, Y ^a   Rhim, H ^b  

^a Seoul Veterans Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; DNA DENATURATION; DNA STRAND BREAKAGE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR NECROSIS;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; TREATMENT OUTCOME;

EID: 73449103246     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.069716     Document Type: Review

References (38)

1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-56.
2. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm. Gastroenterology 2004;127:1714-23.
3. Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151-6.
4. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-30.
5. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 2005;103:1201-9.
6. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 2007;14:2319-29.
7. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007;17:684-92.
8. Livraghi T, Meloni F, Stasi MD, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008;47:82-9.
9. Poon RT, Fan ST, Tsang FH, et al. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002;235:466-86.
10. Fontana RJ, Humidulluh H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002;8:1165-74.
11. Pompili M, Mirante VG, Rondinara G, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant: analysis and of safety for tumor recurrence. Liver Transpl 2005;11:1117-26.
12. Porrett PM, Peterman H, Rosen M, et al. Lack of benefit of pretransplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 2006;12:665-73.
13. Martin AP, Goldstein RM, Dempster J, et al. Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation: a clinical and histological examination. Clin Transplant 2006;20:695-705.
14. Rodríguez-Sanjuán JC, González F, Juanco C, et al. Radiological and pathological assessment of hepatocellular carcinoma response to radiofrequency: a study on removed liver after transplantation. World J Surg 2008;32:1489-94.
15. Poon RT. Is radiofrequency ablation the treatment of choice for patients with small hepatocellular carcinoma? Nat Clin Pract Gastroenterol Hepatol 2008;5:492-3.
16. Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-7.
17. Moritomo M, Sugimori K, Shirato K, et al. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology 2002;35:1467-75.
18. Goldberg SN, Gazelle GS, Compton CC, et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000;88:2452-63.
19. Coad JE, Kosari K, Humar A, et al. Radiofrequency ablation causes thermal fixation of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant 2003;17:377-84.
20. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900-9.
21. Brillet PY, Paradis V, Brancatelli G, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. AJR Am J Roentgenol 2006;186(5 Suppl):S296-305.
22. Nikfarjam M, Malcontenti-Wilson C, Christophi C. Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects. J Gastrointest Surg 2005;9:410-7.
23. Fairbairn JJ, Khan MW, Ward KJ, et al. Introduction of apoptotic cell DNA fragmentation in human cells after treatment with hyperthermia. Cancer Lett 1995;89:183-8.
24. Frankfurt O, Robb JA, Sugarbaker EV, et al. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res 1996;226:387-97.
25. Geske FJ, Gerschenson LE. The biology of apoptosis. Hum Pathol 2001;32:1029-38.
26. Benndorf R, Bielka H. Cellular stress response: stress proteins-physiology and implications for cancer. Recent Results Cancer Res 1997;143:129-44.
27. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990;40:2353-62.
28. Wiersinga WJ, Jansen MC, Straatsburg IH, et al. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 2003;90:306-12.
29. Emami B, Song CW. Physiologic mechanisms in hyperthermia: a review. Int J Radiat Oncol Biol Phys 1984;10:289-95.
30. Sweetland HM, Wyman A, Rogers K. Evaluation of the effect on the normal liver of interstitial laser hyperthermia using artificial sapphire probes. Lasers Med Sci 1993;8:99-105.
31. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005;127:208-23.
32. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119: 493-501.
33. Barth M, Oulmi Y, Ehrenreich H, et al. Pre-embedding immunogold labeling of TUNEL stain enables evaluation of DNA strand breaks and ultrastructural alterations in individual cells of neuron tissue. Acta Neuropathol 2002;104:621-36.
34. Qin HX, Nan KJ, Yang GY, et al. Expression and clinical significance of Tap73, p53, PCNA and apoptosis in hepatocellular carcinoma. World J Gastroenterol 2005;11:2709-13.
35. Netto GJ, Altrabulsi B, Katabi N, et al. Radiofrequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and TUNEL study. Liver Int 2006;26:746-51.
36. Pulvirenti A, Garbagnati F, Regalia E, et al. Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation. Transpl Proc 2001;33:1516-7.
37. Lu D, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005;234:954-60.
38. Lu D, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41:1130-7.